Capitale Di Prestito Cambiamento Data
AbbVie USD 62.48B 2.05B 2026-06
Agios Pharmaceuticals USD 1.06M 0 2022-09
ALKERMES USD 1.47B 5.38M 2026-09
Alnylam Pharmaceuticals USD 2.11B 358.58M 2026-09
Amgen USD 51.61B 250M 2026-09
Biogen USD 7.29B 1.7M 2026-09
BioMarin Pharmaceutical USD 3.51B 12.96M 2026-09
Bristol-Myers Squibb USD 41.85B 244M 2026-09
Coherus Biosciences USD 51.08M 496K 2025-12
Eli Lilly USD 46.99B 872M 2026-09
Gilead Sciences USD 23.82B 17M 2026-09
GlaxoSmithKline GBP 21.7B 7.75B 2026-09
Glaxosmithkline GBP 28.79B 10.26B 2026-09
Incyte USD 28.42M 994K 2026-06
J&J USD 35.8B 1.55B 2026-09
Merck USD 49.69B 1.39B 2026-09
Moderna USD 3.55B 2.95B 2026-09
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 38.38B 893M 2026-09
Pfizer USD 60B 498M 2026-09
PTC Therapeutics USD 536.27M 749K 2026-09
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-09
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 16.28B 1.63B 2026-09
Sarepta Therapeutics USD 699.39M 148.23M 2026-09
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 3.5B 3.39B 2026-09